Drug Type Monoclonal antibody |
Synonyms HB0045 |
Target |
Mechanism CD73 inhibitors(5'-nucleotidase inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Advanced Malignant Solid Neoplasm | Phase 2 | US | 20 Aug 2023 | |
Solid tumor | Phase 2 | US | 18 Jul 2023 | |
Idiopathic Pulmonary Fibrosis | IND Application | CN | 09 Nov 2022 |